BIO Medical Applications Of Pennsylvania, Inc. is a medicare approved dialysis facility center in Philadelphia, Pennsylvania and it has 13 dialysis stations. It is located in Philadelphia county at 700 Cottman Avenue, Philadelphia, PA, 19111. You can reach out to the office of BIO Medical Applications Of Pennsylvania, Inc. at (215) 745-3183. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BIO Medical Applications Of Pennsylvania, Inc. has the following ownership type - Profit. It was first certified by medicare in November, 2016. The medicare id for this facility is 392853 and it accepts patients under medicare ESRD program.
| Name | BIO Medical Applications Of Pennsylvania, Inc. |
|---|---|
| Location | 700 Cottman Avenue, Philadelphia, Pennsylvania |
| No. of Dialysis Stations | 13 |
| Medicare ID | 392853 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 700 Cottman Avenue, Philadelphia, Pennsylvania, 19111 | |
| (215) 745-3183 | |
| Not Available |
| Dialysis patients with Hemoglobin data | 6 |
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 19 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 108 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BIO Medical Applications Of Pennsylvania, Inc. with elevated calcium levels.
| Patients with hypercalcemia | 20 |
| Hypercalcemia patient months | 113 |
| Patients with Serumphosphor | 27 |
| Patients with Serumphosphor less than 3.5 mg/dL | 16 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 19 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 25 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 17 |
| Patient months included in arterial venous fistula and catheter summaries | 107 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 69 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
Albert Einstein Medical Center Location: 5501 Old York Road, Philadelphia, Pennsylvania, 19141 Phone: (215) 456-5871 |
Fresenius Medical Care Philadelphia Location: 4216 Market Street, Philadelphia, Pennsylvania, 19104 Phone: (215) 662-5990 |
Fresenius Medical Care Central Philadelphia Location: 417 North 8th Street, Philadelphia, Pennsylvania, 19123 Phone: (215) 413-3050 |
Davita Northern Philadelphia Location: 5933 North Broad Street, Philadelphia, Pennsylvania, 19141 Phone: (215) 549-5000 |
Davita - West Philadelphia Dialysis Location: 7609 Lindberg Boulevard, Philadelphia, Pennsylvania, 19153 Phone: (215) 937-1103 |